PROVIDER PROFILE · NPI 1487604740

Thomas Welsh

Internal MedicineMesa, AZI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$271

Distinct drugs

Brand share

25.4%

Top prescribed drugs

Prednisone30 claims

Azithromycin20 claims

Amoxicillin/Potassium Clav17 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Thomas Welsh's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 2 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
KIRKPATRICK, JEFFREY	62	103

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
DIGNITY COMMUNITY CARE	66	99
Sonora Quest Laboratories Llc Clinical Laboratory · Phoenix, AZ	12	18

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history